Sorry, you need to enable JavaScript to visit this website.

A clinical trial to find out if PF-06291874 is safe and tolerated by patients with type 2 diabetes mellitus

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of PF-06291874 Given as Monotherapy to Adults With Type 2 Diabetes Mellitus

Category & Conditions: Diabetes and Metabolic Disorders
Medicine: PF-06291874 Identifier (NCT): NCT02175121
Protocol ID: B4801011
Open Plain Language Summary Result: Click here